Jennifer Meyers

Johns Hopkins University — United States

Medicine · Health Sciences

13h-index5.0kcitations33works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(7), Immunotherapy and Immune Responses(7), Cancer Immunotherapy and Biomarkers(6), Single-cell and spatial transcriptomics(4), Radiopharmaceutical Chemistry and Applications(3)

Publications33 total

A transition zone enriched <i>WIF1</i> ⁺ basal cell subtype is associated with benign prostatic hyperplasia
2025Open Access
Factors Contributing to General Anesthesia Appointment Failure.
PubMed·2025
Ossifying Spindled and Epithelioid Tumor: A Novel Soft Tissue Tumor
Modern Pathology·2025· 2 cited
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
Nature Communications·2024· 14 citedOpen Access
Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer
2023· 2 citedOpen Access
Corrigendum: Convergent antibody responses are associated with broad neutralization of hepatitis C virus
Frontiers in Immunology·2023· 4 citedOpen Access
Abstract 2260: Characterizing tumor stromal evolution after neoadjuvant anti-PD-1 therapy in Merkel cell carcinoma
Cancer Research·2023· 1 cited
Abstract 4345: Molecular pathology studies reveal PD1+ CD8 T cell density correlates with response to supraphysiological testosterone treatment in pre-treatment biopsies and MYC mRNA and protein correlate with response after treatment
Cancer Research·2023
Convergent antibody responses are associated with broad neutralization of hepatitis C virus
Frontiers in Immunology·2023· 7 citedOpen Access
Cover Image: Volume 83 Issue 3
The Prostate·2023Open Access
Single‐cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
The Prostate·2022· 25 cited
Androgen receptor activity in prostate cancer dictates efficacy of bipolar androgen therapy through MYC
Journal of Clinical Investigation·2022· 42 citedOpen Access
Abstract 653: Molecular pathology of metastatic prostatic adenocarcinoma treated with bipolar androgen therapy (BAT) reveals a correlation between MYC mRNA and protein
Cancer Research·2022
Overall survival (OS) and biomarker results from combat: A phase 2 study of bipolar androgen therapy (BAT) plus nivolumab for patients with metastatic castrate-resistant prostate cancer (mCRPC).
Journal of Clinical Oncology·2022· 5 cited
Prostate cancer androgen receptor activity dictates efficacy of Bipolar Androgen Therapy
2022· 4 citedOpen Access
Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate
2022Open Access
Single-Cell Atlas of Epithelial and Stromal Cell Heterogeneity by Lobe and Strain in the Mouse Prostate
SSRN Electronic Journal·2022Open Access
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Nature·2021· 13 citedOpen Access
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Nature·2021· 508 citedOpen Access
Pervasive promoter hypermethylation of silenced TERT alleles in human cancers
Cellular Oncology·2020· 20 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Srinivasan Yegnasubramanian(20), Alyza Skaist(15), Ajay Vaghasia(11), Angelo M. De Marzo(11), Rulin Wang(9), Sarah J. Wheelan(9), Mindy K. Graham(9), William G. Nelson(9), Anuj Gupta(8), Jessica Hicks(7), Qizhi Zheng(7), Nicole Castagna(7), Tracy Jones(6), Roshan Chikarmane(6), Brian W. Simons(6), Charles J. Bieberich(6), Theodore L. DeWeese(6), Kornel E. Schuebel(5), Emmanuel S. Antonarakis(5), Mark C. Markowski(5)